FDA Approves 1st Drug for Diabetic Retinopathy

The U.S. Food and Drug Administration on Friday approved the drug Lucentis (ranibizumab) to treat diabetic retinopathy in patients with diabetic macular edema.
Source

Please follow and like us:
Facebook
Facebook
TWITTER
Visit Us
INSTAGRAM

Leave a Comment